chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Extra dose administered, Hypoaesthesia, Inappropriate schedule of product administration, Paraesthesia, Pharyngeal hypoaesthesia
Clinical narrative: ? Patient was vaccinated with booster dose of Pfizer COVID-19 vaccine on 10/15/21 at 13:27 and Patient had what appeared to be a hypersensitivity reaction within 10 minutes of receiving the COVID-19 (Lot: EW0150; Exp 10/31/2021) and flu (Lot: 309616, Exp: 6/30/2022) vaccines.  ? She reported feeling numbness and tingling in the back of her throat, bilateral numbness and tingling on her arms and legs. She also developed a rash behind her ear (she denied scratching or touching the area). Her O2 saturation was 98% and pulse was 89. I called our Medical Director and followed the clinic protocol to administer diphenhydramine 50 mg IM. Patient was monitored for 1 hour. By the end of the monitoring period, her symptoms had resolved, pulse ox remained stable (97%) and pulse was 86. I let her go home with a coworker. ? Patient answered no to all COVID-19 vaccine screening questions and did not divulge that she had reactions to dose 1 and 2. However, when I probed the patient for more information while treating this reaction, the patient reported that she had developed tingling in the back of her throat within 5-10 minutes of prior COVID-19 vaccines but the symptoms resolved without interventions.  ? Other allergies: latex that cause rash ? Patient is not on any home medications
Age: 27.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Pharyngeal paraesthesia, Rash
Clinical narrative: ? Patient was vaccinated with booster dose of Pfizer COVID-19 vaccine on 10/15/21 at 13:27 and Patient had what appeared to be a hypersensitivity reaction within 10 minutes of receiving the COVID-19 (Lot: EW0150; Exp 10/31/2021) and flu (Lot: 309616, Exp: 6/30/2022) vaccines.  ? She reported feeling numbness and tingling in the back of her throat, bilateral numbness and tingling on her arms and legs. She also developed a rash behind her ear (she denied scratching or touching the area). Her O2 saturation was 98% and pulse was 89. I called our Medical Director and followed the clinic protocol to administer diphenhydramine 50 mg IM. Patient was monitored for 1 hour. By the end of the monitoring period, her symptoms had resolved, pulse ox remained stable (97%) and pulse was 86. I let her go home with a coworker. ? Patient answered no to all COVID-19 vaccine screening questions and did not divulge that she had reactions to dose 1 and 2. However, when I probed the patient for more information while treating this reaction, the patient reported that she had developed tingling in the back of her throat within 5-10 minutes of prior COVID-19 vaccines but the symptoms resolved without interventions.  ? Other allergies: latex that cause rash ? Patient is not on any home medications
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: We gave a Moderna shot to a 12 years old who is not eligible for the shot.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Lymphadenopathy
Clinical narrative: PT STARTED TO DEVELOP LT ARM AND SHOULDER AREA PAIN 12 HRS POST INJECTION. BY SUNDAY, NOTICED LT AXILLARY LYMPH NODE ENLARGEMENT
Age: 10.0
Sex: M
Vaccine: FLU4
Symptoms: Abdominal pain, Multisystem inflammatory syndrome in children, Pyrexia
Clinical narrative: Patient developed abdominal pain and fever a few days after his flu vaccine.  He was ultimately diagnosed with MIS-C.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Headache
Clinical narrative: Weakness, occasional headache and dizziness.  Still occurring three days after vaccination.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Lymph node pain, Pain in extremity, Skin warm
Clinical narrative: Sore arm and lymph node. Redness. Hot to touch.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Biopsy skin abnormal, Blood test, Burning sensation, Pityriasis rubra pilaris
Clinical narrative: Developed rash over most of upper body down to upper thighs with intense itching and burning. Excessive skin shedding and hair loss. Diagnosed as PRP - Pityriasis Rubra Pilaris.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Skin exfoliation
Clinical narrative: Developed rash over most of upper body down to upper thighs with intense itching and burning. Excessive skin shedding and hair loss. Diagnosed as PRP - Pityriasis Rubra Pilaris.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: Heavy clotting and menstrual bleeding began the day after the vaccine and has been going on for 12 days.  This is abnormal for me as I was premenopausal.   I do hear this is a common side affect so I'm not to worried.  I think this should be reported as an adverse affect to warn women that may be experiencing the same issues and as a precaution and strictly as information about potential side effects.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Blood albumin decreased, Blood fibrinogen increased, Blood lactate dehydrogenase increased, Blood lactic acid increased
Clinical narrative: Breakthrough Case Received Pfizer with 1st dose on 02/19/2021 and 2nd dose on 03/12/2021.  Per ED Note: Patient is an 84-year-old man that presents the emergency department chief complaint of DIB.  Patient states over the course of the last 3 days he has experienced intermittent chest pain as well as DIB and fevers at home.  Patient states that he is Covid vaccinated from April.  Patient denies anyone else been sick at home.  Patient denies any histories of heart attacks or strokes.  Patient has 1-2 word dyspnea and unable to answer many more questions at this time.  History limited secondary to critical condition. Per H & P: 84-year-old male with history of smoker. Patient was seen in ER for complaints of difficulty breathing and was found to have COVID-19 infection. For the past 3 days prior to admission, patient reportedly had increasing difficulty breathing as well as chest pain and fevers at home. There was no report of any cough or sputum production. Patient reportedly had complaints of fever/chills but there were no reported other URI symptoms such as sore throat or sinus congestion and there were no known sick contacts or COVID-19 positive contacts. There was no reported loss of taste or smell. Patient reportedly had some chest discomfort but details were difficult to obtain because of respiratory distress and conversational dyspnea. There were no reported palpitations or diaphoresis. There was no report of any nausea/vomiting, abdominal pain or diarrhea. It is noted that patient's past medical history could not be obtained due to his critical condition but there was no report of any patient being on any medications at home. In ER, CXR showed bilateral parenchymal changes more pronounced on the left - most consistent with pneumonia. CT angiogram of the chest was negative for pulmonary emboli but it did show COPD with severe peripheral fibrotic markings and patchy and confluent ground-glass densities of the lungs are consistent with viral pneumonia - particularly COVID-19 pneumonitis. EKG showed supraventricular tachycardia with fusion complexes and nonspecific ST-T abnormalities but there were no acute ischemic changes. Labs were significant for leukocytosis with WBC = 17.81, elevated ProTime/INR = 14.8/1.25, elevated fibrinogen = 484, elevated D-dimer = 1230, elevated BUN = 28, hyponatremia with Na = 129, hypokalemia with K = 2.5, low albumin/elevated globulin = 3.2/3.9, elevated LDH = 275, elevated lactic acid = 2.7 and a positive COVID-19 PCR. Patient was admitted for COVID-19 infection / pneumonia / respiratory failure.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium decreased, Blood sodium decreased, Blood urea increased, COVID-19, COVID-19 pneumonia
Clinical narrative: Breakthrough Case Received Pfizer with 1st dose on 02/19/2021 and 2nd dose on 03/12/2021.  Per ED Note: Patient is an 84-year-old man that presents the emergency department chief complaint of DIB.  Patient states over the course of the last 3 days he has experienced intermittent chest pain as well as DIB and fevers at home.  Patient states that he is Covid vaccinated from April.  Patient denies anyone else been sick at home.  Patient denies any histories of heart attacks or strokes.  Patient has 1-2 word dyspnea and unable to answer many more questions at this time.  History limited secondary to critical condition. Per H & P: 84-year-old male with history of smoker. Patient was seen in ER for complaints of difficulty breathing and was found to have COVID-19 infection. For the past 3 days prior to admission, patient reportedly had increasing difficulty breathing as well as chest pain and fevers at home. There was no report of any cough or sputum production. Patient reportedly had complaints of fever/chills but there were no reported other URI symptoms such as sore throat or sinus congestion and there were no known sick contacts or COVID-19 positive contacts. There was no reported loss of taste or smell. Patient reportedly had some chest discomfort but details were difficult to obtain because of respiratory distress and conversational dyspnea. There were no reported palpitations or diaphoresis. There was no report of any nausea/vomiting, abdominal pain or diarrhea. It is noted that patient's past medical history could not be obtained due to his critical condition but there was no report of any patient being on any medications at home. In ER, CXR showed bilateral parenchymal changes more pronounced on the left - most consistent with pneumonia. CT angiogram of the chest was negative for pulmonary emboli but it did show COPD with severe peripheral fibrotic markings and patchy and confluent ground-glass densities of the lungs are consistent with viral pneumonia - particularly COVID-19 pneumonitis. EKG showed supraventricular tachycardia with fusion complexes and nonspecific ST-T abnormalities but there were no acute ischemic changes. Labs were significant for leukocytosis with WBC = 17.81, elevated ProTime/INR = 14.8/1.25, elevated fibrinogen = 484, elevated D-dimer = 1230, elevated BUN = 28, hyponatremia with Na = 129, hypokalemia with K = 2.5, low albumin/elevated globulin = 3.2/3.9, elevated LDH = 275, elevated lactic acid = 2.7 and a positive COVID-19 PCR. Patient was admitted for COVID-19 infection / pneumonia / respiratory failure.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chest discomfort, Chest pain, Chills, Chronic obstructive pulmonary disease
Clinical narrative: Breakthrough Case Received Pfizer with 1st dose on 02/19/2021 and 2nd dose on 03/12/2021.  Per ED Note: Patient is an 84-year-old man that presents the emergency department chief complaint of DIB.  Patient states over the course of the last 3 days he has experienced intermittent chest pain as well as DIB and fevers at home.  Patient states that he is Covid vaccinated from April.  Patient denies anyone else been sick at home.  Patient denies any histories of heart attacks or strokes.  Patient has 1-2 word dyspnea and unable to answer many more questions at this time.  History limited secondary to critical condition. Per H & P: 84-year-old male with history of smoker. Patient was seen in ER for complaints of difficulty breathing and was found to have COVID-19 infection. For the past 3 days prior to admission, patient reportedly had increasing difficulty breathing as well as chest pain and fevers at home. There was no report of any cough or sputum production. Patient reportedly had complaints of fever/chills but there were no reported other URI symptoms such as sore throat or sinus congestion and there were no known sick contacts or COVID-19 positive contacts. There was no reported loss of taste or smell. Patient reportedly had some chest discomfort but details were difficult to obtain because of respiratory distress and conversational dyspnea. There were no reported palpitations or diaphoresis. There was no report of any nausea/vomiting, abdominal pain or diarrhea. It is noted that patient's past medical history could not be obtained due to his critical condition but there was no report of any patient being on any medications at home. In ER, CXR showed bilateral parenchymal changes more pronounced on the left - most consistent with pneumonia. CT angiogram of the chest was negative for pulmonary emboli but it did show COPD with severe peripheral fibrotic markings and patchy and confluent ground-glass densities of the lungs are consistent with viral pneumonia - particularly COVID-19 pneumonitis. EKG showed supraventricular tachycardia with fusion complexes and nonspecific ST-T abnormalities but there were no acute ischemic changes. Labs were significant for leukocytosis with WBC = 17.81, elevated ProTime/INR = 14.8/1.25, elevated fibrinogen = 484, elevated D-dimer = 1230, elevated BUN = 28, hyponatremia with Na = 129, hypokalemia with K = 2.5, low albumin/elevated globulin = 3.2/3.9, elevated LDH = 275, elevated lactic acid = 2.7 and a positive COVID-19 PCR. Patient was admitted for COVID-19 infection / pneumonia / respiratory failure.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram QRS complex abnormal, Electrocardiogram ST-T segment abnormal, Electrocardiogram abnormal, Fibrin D dimer increased
Clinical narrative: Breakthrough Case Received Pfizer with 1st dose on 02/19/2021 and 2nd dose on 03/12/2021.  Per ED Note: Patient is an 84-year-old man that presents the emergency department chief complaint of DIB.  Patient states over the course of the last 3 days he has experienced intermittent chest pain as well as DIB and fevers at home.  Patient states that he is Covid vaccinated from April.  Patient denies anyone else been sick at home.  Patient denies any histories of heart attacks or strokes.  Patient has 1-2 word dyspnea and unable to answer many more questions at this time.  History limited secondary to critical condition. Per H & P: 84-year-old male with history of smoker. Patient was seen in ER for complaints of difficulty breathing and was found to have COVID-19 infection. For the past 3 days prior to admission, patient reportedly had increasing difficulty breathing as well as chest pain and fevers at home. There was no report of any cough or sputum production. Patient reportedly had complaints of fever/chills but there were no reported other URI symptoms such as sore throat or sinus congestion and there were no known sick contacts or COVID-19 positive contacts. There was no reported loss of taste or smell. Patient reportedly had some chest discomfort but details were difficult to obtain because of respiratory distress and conversational dyspnea. There were no reported palpitations or diaphoresis. There was no report of any nausea/vomiting, abdominal pain or diarrhea. It is noted that patient's past medical history could not be obtained due to his critical condition but there was no report of any patient being on any medications at home. In ER, CXR showed bilateral parenchymal changes more pronounced on the left - most consistent with pneumonia. CT angiogram of the chest was negative for pulmonary emboli but it did show COPD with severe peripheral fibrotic markings and patchy and confluent ground-glass densities of the lungs are consistent with viral pneumonia - particularly COVID-19 pneumonitis. EKG showed supraventricular tachycardia with fusion complexes and nonspecific ST-T abnormalities but there were no acute ischemic changes. Labs were significant for leukocytosis with WBC = 17.81, elevated ProTime/INR = 14.8/1.25, elevated fibrinogen = 484, elevated D-dimer = 1230, elevated BUN = 28, hyponatremia with Na = 129, hypokalemia with K = 2.5, low albumin/elevated globulin = 3.2/3.9, elevated LDH = 275, elevated lactic acid = 2.7 and a positive COVID-19 PCR. Patient was admitted for COVID-19 infection / pneumonia / respiratory failure.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Globulins increased, Hypokalaemia, Hyponatraemia, International normalised ratio increased
Clinical narrative: Breakthrough Case Received Pfizer with 1st dose on 02/19/2021 and 2nd dose on 03/12/2021.  Per ED Note: Patient is an 84-year-old man that presents the emergency department chief complaint of DIB.  Patient states over the course of the last 3 days he has experienced intermittent chest pain as well as DIB and fevers at home.  Patient states that he is Covid vaccinated from April.  Patient denies anyone else been sick at home.  Patient denies any histories of heart attacks or strokes.  Patient has 1-2 word dyspnea and unable to answer many more questions at this time.  History limited secondary to critical condition. Per H & P: 84-year-old male with history of smoker. Patient was seen in ER for complaints of difficulty breathing and was found to have COVID-19 infection. For the past 3 days prior to admission, patient reportedly had increasing difficulty breathing as well as chest pain and fevers at home. There was no report of any cough or sputum production. Patient reportedly had complaints of fever/chills but there were no reported other URI symptoms such as sore throat or sinus congestion and there were no known sick contacts or COVID-19 positive contacts. There was no reported loss of taste or smell. Patient reportedly had some chest discomfort but details were difficult to obtain because of respiratory distress and conversational dyspnea. There were no reported palpitations or diaphoresis. There was no report of any nausea/vomiting, abdominal pain or diarrhea. It is noted that patient's past medical history could not be obtained due to his critical condition but there was no report of any patient being on any medications at home. In ER, CXR showed bilateral parenchymal changes more pronounced on the left - most consistent with pneumonia. CT angiogram of the chest was negative for pulmonary emboli but it did show COPD with severe peripheral fibrotic markings and patchy and confluent ground-glass densities of the lungs are consistent with viral pneumonia - particularly COVID-19 pneumonitis. EKG showed supraventricular tachycardia with fusion complexes and nonspecific ST-T abnormalities but there were no acute ischemic changes. Labs were significant for leukocytosis with WBC = 17.81, elevated ProTime/INR = 14.8/1.25, elevated fibrinogen = 484, elevated D-dimer = 1230, elevated BUN = 28, hyponatremia with Na = 129, hypokalemia with K = 2.5, low albumin/elevated globulin = 3.2/3.9, elevated LDH = 275, elevated lactic acid = 2.7 and a positive COVID-19 PCR. Patient was admitted for COVID-19 infection / pneumonia / respiratory failure.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Leukocytosis, Lung opacity, Pneumonia, Pneumonia viral, Prothrombin time prolonged
Clinical narrative: Breakthrough Case Received Pfizer with 1st dose on 02/19/2021 and 2nd dose on 03/12/2021.  Per ED Note: Patient is an 84-year-old man that presents the emergency department chief complaint of DIB.  Patient states over the course of the last 3 days he has experienced intermittent chest pain as well as DIB and fevers at home.  Patient states that he is Covid vaccinated from April.  Patient denies anyone else been sick at home.  Patient denies any histories of heart attacks or strokes.  Patient has 1-2 word dyspnea and unable to answer many more questions at this time.  History limited secondary to critical condition. Per H & P: 84-year-old male with history of smoker. Patient was seen in ER for complaints of difficulty breathing and was found to have COVID-19 infection. For the past 3 days prior to admission, patient reportedly had increasing difficulty breathing as well as chest pain and fevers at home. There was no report of any cough or sputum production. Patient reportedly had complaints of fever/chills but there were no reported other URI symptoms such as sore throat or sinus congestion and there were no known sick contacts or COVID-19 positive contacts. There was no reported loss of taste or smell. Patient reportedly had some chest discomfort but details were difficult to obtain because of respiratory distress and conversational dyspnea. There were no reported palpitations or diaphoresis. There was no report of any nausea/vomiting, abdominal pain or diarrhea. It is noted that patient's past medical history could not be obtained due to his critical condition but there was no report of any patient being on any medications at home. In ER, CXR showed bilateral parenchymal changes more pronounced on the left - most consistent with pneumonia. CT angiogram of the chest was negative for pulmonary emboli but it did show COPD with severe peripheral fibrotic markings and patchy and confluent ground-glass densities of the lungs are consistent with viral pneumonia - particularly COVID-19 pneumonitis. EKG showed supraventricular tachycardia with fusion complexes and nonspecific ST-T abnormalities but there were no acute ischemic changes. Labs were significant for leukocytosis with WBC = 17.81, elevated ProTime/INR = 14.8/1.25, elevated fibrinogen = 484, elevated D-dimer = 1230, elevated BUN = 28, hyponatremia with Na = 129, hypokalemia with K = 2.5, low albumin/elevated globulin = 3.2/3.9, elevated LDH = 275, elevated lactic acid = 2.7 and a positive COVID-19 PCR. Patient was admitted for COVID-19 infection / pneumonia / respiratory failure.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary fibrosis, Pyrexia, Respiratory distress, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Breakthrough Case Received Pfizer with 1st dose on 02/19/2021 and 2nd dose on 03/12/2021.  Per ED Note: Patient is an 84-year-old man that presents the emergency department chief complaint of DIB.  Patient states over the course of the last 3 days he has experienced intermittent chest pain as well as DIB and fevers at home.  Patient states that he is Covid vaccinated from April.  Patient denies anyone else been sick at home.  Patient denies any histories of heart attacks or strokes.  Patient has 1-2 word dyspnea and unable to answer many more questions at this time.  History limited secondary to critical condition. Per H & P: 84-year-old male with history of smoker. Patient was seen in ER for complaints of difficulty breathing and was found to have COVID-19 infection. For the past 3 days prior to admission, patient reportedly had increasing difficulty breathing as well as chest pain and fevers at home. There was no report of any cough or sputum production. Patient reportedly had complaints of fever/chills but there were no reported other URI symptoms such as sore throat or sinus congestion and there were no known sick contacts or COVID-19 positive contacts. There was no reported loss of taste or smell. Patient reportedly had some chest discomfort but details were difficult to obtain because of respiratory distress and conversational dyspnea. There were no reported palpitations or diaphoresis. There was no report of any nausea/vomiting, abdominal pain or diarrhea. It is noted that patient's past medical history could not be obtained due to his critical condition but there was no report of any patient being on any medications at home. In ER, CXR showed bilateral parenchymal changes more pronounced on the left - most consistent with pneumonia. CT angiogram of the chest was negative for pulmonary emboli but it did show COPD with severe peripheral fibrotic markings and patchy and confluent ground-glass densities of the lungs are consistent with viral pneumonia - particularly COVID-19 pneumonitis. EKG showed supraventricular tachycardia with fusion complexes and nonspecific ST-T abnormalities but there were no acute ischemic changes. Labs were significant for leukocytosis with WBC = 17.81, elevated ProTime/INR = 14.8/1.25, elevated fibrinogen = 484, elevated D-dimer = 1230, elevated BUN = 28, hyponatremia with Na = 129, hypokalemia with K = 2.5, low albumin/elevated globulin = 3.2/3.9, elevated LDH = 275, elevated lactic acid = 2.7 and a positive COVID-19 PCR. Patient was admitted for COVID-19 infection / pneumonia / respiratory failure.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Supraventricular tachycardia, Vaccine breakthrough infection, White blood cell count increased
Clinical narrative: Breakthrough Case Received Pfizer with 1st dose on 02/19/2021 and 2nd dose on 03/12/2021.  Per ED Note: Patient is an 84-year-old man that presents the emergency department chief complaint of DIB.  Patient states over the course of the last 3 days he has experienced intermittent chest pain as well as DIB and fevers at home.  Patient states that he is Covid vaccinated from April.  Patient denies anyone else been sick at home.  Patient denies any histories of heart attacks or strokes.  Patient has 1-2 word dyspnea and unable to answer many more questions at this time.  History limited secondary to critical condition. Per H & P: 84-year-old male with history of smoker. Patient was seen in ER for complaints of difficulty breathing and was found to have COVID-19 infection. For the past 3 days prior to admission, patient reportedly had increasing difficulty breathing as well as chest pain and fevers at home. There was no report of any cough or sputum production. Patient reportedly had complaints of fever/chills but there were no reported other URI symptoms such as sore throat or sinus congestion and there were no known sick contacts or COVID-19 positive contacts. There was no reported loss of taste or smell. Patient reportedly had some chest discomfort but details were difficult to obtain because of respiratory distress and conversational dyspnea. There were no reported palpitations or diaphoresis. There was no report of any nausea/vomiting, abdominal pain or diarrhea. It is noted that patient's past medical history could not be obtained due to his critical condition but there was no report of any patient being on any medications at home. In ER, CXR showed bilateral parenchymal changes more pronounced on the left - most consistent with pneumonia. CT angiogram of the chest was negative for pulmonary emboli but it did show COPD with severe peripheral fibrotic markings and patchy and confluent ground-glass densities of the lungs are consistent with viral pneumonia - particularly COVID-19 pneumonitis. EKG showed supraventricular tachycardia with fusion complexes and nonspecific ST-T abnormalities but there were no acute ischemic changes. Labs were significant for leukocytosis with WBC = 17.81, elevated ProTime/INR = 14.8/1.25, elevated fibrinogen = 484, elevated D-dimer = 1230, elevated BUN = 28, hyponatremia with Na = 129, hypokalemia with K = 2.5, low albumin/elevated globulin = 3.2/3.9, elevated LDH = 275, elevated lactic acid = 2.7 and a positive COVID-19 PCR. Patient was admitted for COVID-19 infection / pneumonia / respiratory failure.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Injection site urticaria
Clinical narrative: Large rash/hives on injection site arm.  Treated with oral (benydryl) and topical (2% diphenhydramine hydrochloride) allergy medication and anti-itch cream (1% hydrocortisone).  Lasted 2 weeks.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Fall, Gait disturbance, Hypoaesthesia, Muscular weakness
Clinical narrative: I took the first shot in my right arm, I had no pain at all with the injection, it wasn?t until the August 26, 2021 when I got out of bed and went to my bathroom in pain and stumbling my leg gave out on me I had numbness and shooting  pain  in my right calf and down to my right foot it was an is still got the same burning, tingling, and numbness in my right leg and foot as of today 10/25/2021.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paraesthesia
Clinical narrative: I took the first shot in my right arm, I had no pain at all with the injection, it wasn?t until the August 26, 2021 when I got out of bed and went to my bathroom in pain and stumbling my leg gave out on me I had numbness and shooting  pain  in my right calf and down to my right foot it was an is still got the same burning, tingling, and numbness in my right leg and foot as of today 10/25/2021.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Small red mark on bottom of index finger and one on left foot.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac disorder, Fatigue
Clinical narrative: I experienced extreme tiredness, heart condition
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative
Clinical narrative: I had a cold, congestion, runny nose. The reason I went to urgent care, it turned into a pretty harsh cough. Needed treatment for relief. Physician said my lungs sounded fine. She said prescribed Prednisone and Benzonatate. Those are helping me with symptoms. I am still taking those meds at the time.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Immunodeficiency, Myalgia
Clinical narrative: Headache & Muscle aches day 1  Fever, Chills, Muscle Aches, Fatigue day 2 Headache day 3
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache & Muscle aches day 1  Fever, Chills, Muscle Aches, Fatigue day 2 Headache day 3
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest discomfort, Electrocardiogram, Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: I got the booster along with the flu shot and shingles booster and have been experiencing chest pressure .
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: the vaccine was expired ,was over 6 hours and was left at room temperature
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fall, Pain, Pollakiuria
Clinical narrative: After falling asleep for the night, I awoke 8 hours after the vaccine and was chilling and achy. I needed to void and went a very large amount (I had peed and emptied fully before going to bed). I awoke for 2 more significant voids during the night and by the 3:30am bathroom trip I was trembling and light headed with blurry vision. After voiding, I walked toward the bedroom door and the next thing I remember is my legs buckling and I then woke up to find myself sitting on the bathroom floor, fortunately uninjured. My guess is that I fainted (and I have never fainted before).  I got back to bed and slept till 8am but until 11 am had light headedness/ blurry vision and tremors in my hands (also a symptom I have never experienced).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Tremor, Vision blurred
Clinical narrative: After falling asleep for the night, I awoke 8 hours after the vaccine and was chilling and achy. I needed to void and went a very large amount (I had peed and emptied fully before going to bed). I awoke for 2 more significant voids during the night and by the 3:30am bathroom trip I was trembling and light headed with blurry vision. After voiding, I walked toward the bedroom door and the next thing I remember is my legs buckling and I then woke up to find myself sitting on the bathroom floor, fortunately uninjured. My guess is that I fainted (and I have never fainted before).  I got back to bed and slept till 8am but until 11 am had light headedness/ blurry vision and tremors in my hands (also a symptom I have never experienced).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Dyspnoea, Echocardiogram, Electrocardiogram, Palpitations
Clinical narrative: Sudden onset of pounding heart, buzzing sensation throughout body, near blackouts, and shortness of breath.  Buzzing sensation and near blackouts have subsided during past two weeks, but pounding heart and shortness of breath continue on a constant basis.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Presyncope, Sensory disturbance
Clinical narrative: Sudden onset of pounding heart, buzzing sensation throughout body, near blackouts, and shortness of breath.  Buzzing sensation and near blackouts have subsided during past two weeks, but pounding heart and shortness of breath continue on a constant basis.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: Covid booster given to early second dose give 5/21/21 and booster dose given 10/25/21
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Bladder catheterisation, Bladder irrigation, COVID-19, Chest X-ray abnormal
Clinical narrative: BREAKTHOUGH CASE Patient Covid + on 10/23/2021 patient received Pfizer on 02/05/2021 and then received Janssen on 03/18/2021. Per H & P :  Gross hematuria, recurrent  Atrial fibrillation with intermittent RVR  Severe cardiomyopathy with EF of 15-20%  Acute blood loss anemia, monitor hemoglobin  Tobacco abuse  Debility  Urinary retention s/p Foley catheter placement  Severe valvular disease with severe MR, severe TR and moderate aortic insufficiency  S/p recent TIA   The patient was seen by neurology  Foley catheter was placed  Bladder irrigation as needed  Monitor hemoglobin  Transfuse as needed  Monitor kidney function  IV antibiotic Continue with current treatment. Medication, lab and chart reviewed.          Chief Complaint   Acute recurrent gross hematuria  History of Present Illness     None this is a 74-year-old male with a past medical history significant for severe cardiomyopathy, severe valvular heart disease, atrial fibrillation, on anticoagulation who was sent from ECF because of recurrent severe gross hematuria.  The patient also confusion which was most likely secondary to UTI and multiple medical issues.  The patient does not have any fever chills no nausea no vomiting no abdominal pain.  Patient was seen by urology, Foley catheter was replaced.   Past medical history:  Hypertension  Recently diagnosed severe systolic CHF with EF of 15-20%  New onset atrial fibrillation, recently diagnosed  Hypertension  Debility  Hematuria Per ID Consult Note:   COVID-19 pneumonia.  Congestive heart failure and cardiomyopathy.  Tobacco abuse.  Debility.   Recommendations  Continue dexamethasone.  Add remdesivir.  Continue oxygen support/respiratory support.  Consult pulmonology.  Cardiology is following. History of Present Illness : 74-year-old male who was admitted with a chief complaint of weakness and urinary retention.  That was corrected however he was found to be very debilitated and weak and gradually he became hypoxic chest x-ray showed bilateral infiltrates and a COVID-19 test was positive.  The onset of illness about 4- 5 days ago.  No diarrhea no abdominal pain dysuria polyuria or hematuria.  No hemoptysis or chest pain.  On questioning the patient tells me he feels okay but he is certainly becoming more hypoxic and requiring more oxygen.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Confusional state, Haematuria, Hypoxia, Interchange of vaccine products
Clinical narrative: BREAKTHOUGH CASE Patient Covid + on 10/23/2021 patient received Pfizer on 02/05/2021 and then received Janssen on 03/18/2021. Per H & P :  Gross hematuria, recurrent  Atrial fibrillation with intermittent RVR  Severe cardiomyopathy with EF of 15-20%  Acute blood loss anemia, monitor hemoglobin  Tobacco abuse  Debility  Urinary retention s/p Foley catheter placement  Severe valvular disease with severe MR, severe TR and moderate aortic insufficiency  S/p recent TIA   The patient was seen by neurology  Foley catheter was placed  Bladder irrigation as needed  Monitor hemoglobin  Transfuse as needed  Monitor kidney function  IV antibiotic Continue with current treatment. Medication, lab and chart reviewed.          Chief Complaint   Acute recurrent gross hematuria  History of Present Illness     None this is a 74-year-old male with a past medical history significant for severe cardiomyopathy, severe valvular heart disease, atrial fibrillation, on anticoagulation who was sent from ECF because of recurrent severe gross hematuria.  The patient also confusion which was most likely secondary to UTI and multiple medical issues.  The patient does not have any fever chills no nausea no vomiting no abdominal pain.  Patient was seen by urology, Foley catheter was replaced.   Past medical history:  Hypertension  Recently diagnosed severe systolic CHF with EF of 15-20%  New onset atrial fibrillation, recently diagnosed  Hypertension  Debility  Hematuria Per ID Consult Note:   COVID-19 pneumonia.  Congestive heart failure and cardiomyopathy.  Tobacco abuse.  Debility.   Recommendations  Continue dexamethasone.  Add remdesivir.  Continue oxygen support/respiratory support.  Consult pulmonology.  Cardiology is following. History of Present Illness : 74-year-old male who was admitted with a chief complaint of weakness and urinary retention.  That was corrected however he was found to be very debilitated and weak and gradually he became hypoxic chest x-ray showed bilateral infiltrates and a COVID-19 test was positive.  The onset of illness about 4- 5 days ago.  No diarrhea no abdominal pain dysuria polyuria or hematuria.  No hemoptysis or chest pain.  On questioning the patient tells me he feels okay but he is certainly becoming more hypoxic and requiring more oxygen.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Lung infiltration, SARS-CoV-2 test positive, Transfusion, Urinary retention, Urinary tract infection
Clinical narrative: BREAKTHOUGH CASE Patient Covid + on 10/23/2021 patient received Pfizer on 02/05/2021 and then received Janssen on 03/18/2021. Per H & P :  Gross hematuria, recurrent  Atrial fibrillation with intermittent RVR  Severe cardiomyopathy with EF of 15-20%  Acute blood loss anemia, monitor hemoglobin  Tobacco abuse  Debility  Urinary retention s/p Foley catheter placement  Severe valvular disease with severe MR, severe TR and moderate aortic insufficiency  S/p recent TIA   The patient was seen by neurology  Foley catheter was placed  Bladder irrigation as needed  Monitor hemoglobin  Transfuse as needed  Monitor kidney function  IV antibiotic Continue with current treatment. Medication, lab and chart reviewed.          Chief Complaint   Acute recurrent gross hematuria  History of Present Illness     None this is a 74-year-old male with a past medical history significant for severe cardiomyopathy, severe valvular heart disease, atrial fibrillation, on anticoagulation who was sent from ECF because of recurrent severe gross hematuria.  The patient also confusion which was most likely secondary to UTI and multiple medical issues.  The patient does not have any fever chills no nausea no vomiting no abdominal pain.  Patient was seen by urology, Foley catheter was replaced.   Past medical history:  Hypertension  Recently diagnosed severe systolic CHF with EF of 15-20%  New onset atrial fibrillation, recently diagnosed  Hypertension  Debility  Hematuria Per ID Consult Note:   COVID-19 pneumonia.  Congestive heart failure and cardiomyopathy.  Tobacco abuse.  Debility.   Recommendations  Continue dexamethasone.  Add remdesivir.  Continue oxygen support/respiratory support.  Consult pulmonology.  Cardiology is following. History of Present Illness : 74-year-old male who was admitted with a chief complaint of weakness and urinary retention.  That was corrected however he was found to be very debilitated and weak and gradually he became hypoxic chest x-ray showed bilateral infiltrates and a COVID-19 test was positive.  The onset of illness about 4- 5 days ago.  No diarrhea no abdominal pain dysuria polyuria or hematuria.  No hemoptysis or chest pain.  On questioning the patient tells me he feels okay but he is certainly becoming more hypoxic and requiring more oxygen.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: BREAKTHOUGH CASE Patient Covid + on 10/23/2021 patient received Pfizer on 02/05/2021 and then received Janssen on 03/18/2021. Per H & P :  Gross hematuria, recurrent  Atrial fibrillation with intermittent RVR  Severe cardiomyopathy with EF of 15-20%  Acute blood loss anemia, monitor hemoglobin  Tobacco abuse  Debility  Urinary retention s/p Foley catheter placement  Severe valvular disease with severe MR, severe TR and moderate aortic insufficiency  S/p recent TIA   The patient was seen by neurology  Foley catheter was placed  Bladder irrigation as needed  Monitor hemoglobin  Transfuse as needed  Monitor kidney function  IV antibiotic Continue with current treatment. Medication, lab and chart reviewed.          Chief Complaint   Acute recurrent gross hematuria  History of Present Illness     None this is a 74-year-old male with a past medical history significant for severe cardiomyopathy, severe valvular heart disease, atrial fibrillation, on anticoagulation who was sent from ECF because of recurrent severe gross hematuria.  The patient also confusion which was most likely secondary to UTI and multiple medical issues.  The patient does not have any fever chills no nausea no vomiting no abdominal pain.  Patient was seen by urology, Foley catheter was replaced.   Past medical history:  Hypertension  Recently diagnosed severe systolic CHF with EF of 15-20%  New onset atrial fibrillation, recently diagnosed  Hypertension  Debility  Hematuria Per ID Consult Note:   COVID-19 pneumonia.  Congestive heart failure and cardiomyopathy.  Tobacco abuse.  Debility.   Recommendations  Continue dexamethasone.  Add remdesivir.  Continue oxygen support/respiratory support.  Consult pulmonology.  Cardiology is following. History of Present Illness : 74-year-old male who was admitted with a chief complaint of weakness and urinary retention.  That was corrected however he was found to be very debilitated and weak and gradually he became hypoxic chest x-ray showed bilateral infiltrates and a COVID-19 test was positive.  The onset of illness about 4- 5 days ago.  No diarrhea no abdominal pain dysuria polyuria or hematuria.  No hemoptysis or chest pain.  On questioning the patient tells me he feels okay but he is certainly becoming more hypoxic and requiring more oxygen.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Experienced chills and tactile fever 16 hours after injection and fatigue x 24 hours.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Cough, Diarrhoea, Dyspnoea
Clinical narrative: SEE BELOW
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Fatigue, Nausea, Pain, SARS-CoV-2 test positive
Clinical narrative: SEE BELOW
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: SEE BELOW
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Atrial fibrillation, COVID-19, Chest X-ray abnormal, Diarrhoea
Clinical narrative: 10/17/21 SEEN IN THE ER THEN ADMITTED: WITH ACUTE RENAL FAILURE, AKI, AFEB, COVID-19, DIARRHEA DUE TO COVID -19, FEVER. SYNCOPE. CHEST XRAY SHOWING DEVELOPING PNEUMONIA, REQUIRED OXYGEN. 10/24 DISHCHARGED HOME WITH OXYGEN. 2 L.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia, Pyrexia, SARS-CoV-2 test positive, Syncope
Clinical narrative: 10/17/21 SEEN IN THE ER THEN ADMITTED: WITH ACUTE RENAL FAILURE, AKI, AFEB, COVID-19, DIARRHEA DUE TO COVID -19, FEVER. SYNCOPE. CHEST XRAY SHOWING DEVELOPING PNEUMONIA, REQUIRED OXYGEN. 10/24 DISHCHARGED HOME WITH OXYGEN. 2 L.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Fever 101.6°F. Arm pain. Severe fatigue. Lethargy. Chills. Site swelling with redness and pain. 2 days later nodule swollen and painful in armpit.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Nodule, Pain in extremity, Pyrexia
Clinical narrative: Fever 101.6°F. Arm pain. Severe fatigue. Lethargy. Chills. Site swelling with redness and pain. 2 days later nodule swollen and painful in armpit.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Chills, Heart rate increased, Pyrexia, Respiratory rate increased
Clinical narrative: Fever (102.9), chills, increase heart rate,  increase B/P, and increase breathing.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Developed hives all over body, lasting 10 days.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea all day long.  My wife did the same vaccine, same time and she puked night of vaccination.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Musculoskeletal stiffness, Pain in extremity, Physical examination
Clinical narrative: My arm was sore and stiff for a couple days after and at around 4 day mark hard for me to even lift my arm. Started massages and exercises to work it out. At 6 months. still had an issue and went to see the doctor. Physical Therapy was prescribed and referred. Currently feeling better but not out of the woods yet.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory distress syndrome, Acute respiratory failure, Asthenia, COVID-19
Clinical narrative: This is a case of breakthrough COVID-19 disease that resulted in death.   The patient became symptomatic while on a trip out of state. Several other people on this trip were also ill with COVID-19.   This case was vaccinated with the Pfizer product on 02/19/2021 and 03/13/2021. The case became symptomatic for COVID-19 on 09/21/2021 and experienced symptoms of diarrhea, general weakness, fatigue, and sore throat. The exact timeline here is not clear, but over the course of the following days, the case developed difficulty breathing and was admitted to the hospital on 09/27/2021.. The case subsequently died on 10/01/2021.   The death certificate details are as follows:  Part I Cause of Death A: Acute Hypoxic Respiratory Failure B: COVID 19 Pneumonia; Adult Respiratory Distress Syndrome Part II Other Significant Conditions: Acute Kidney Failure; Acute Metabolic Encephalopathy
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Condition aggravated, Death, Diarrhoea, Dyspnoea
Clinical narrative: This is a case of breakthrough COVID-19 disease that resulted in death.   The patient became symptomatic while on a trip out of state. Several other people on this trip were also ill with COVID-19.   This case was vaccinated with the Pfizer product on 02/19/2021 and 03/13/2021. The case became symptomatic for COVID-19 on 09/21/2021 and experienced symptoms of diarrhea, general weakness, fatigue, and sore throat. The exact timeline here is not clear, but over the course of the following days, the case developed difficulty breathing and was admitted to the hospital on 09/27/2021.. The case subsequently died on 10/01/2021.   The death certificate details are as follows:  Part I Cause of Death A: Acute Hypoxic Respiratory Failure B: COVID 19 Pneumonia; Adult Respiratory Distress Syndrome Part II Other Significant Conditions: Acute Kidney Failure; Acute Metabolic Encephalopathy
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Malaise, Metabolic encephalopathy, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: This is a case of breakthrough COVID-19 disease that resulted in death.   The patient became symptomatic while on a trip out of state. Several other people on this trip were also ill with COVID-19.   This case was vaccinated with the Pfizer product on 02/19/2021 and 03/13/2021. The case became symptomatic for COVID-19 on 09/21/2021 and experienced symptoms of diarrhea, general weakness, fatigue, and sore throat. The exact timeline here is not clear, but over the course of the following days, the case developed difficulty breathing and was admitted to the hospital on 09/27/2021.. The case subsequently died on 10/01/2021.   The death certificate details are as follows:  Part I Cause of Death A: Acute Hypoxic Respiratory Failure B: COVID 19 Pneumonia; Adult Respiratory Distress Syndrome Part II Other Significant Conditions: Acute Kidney Failure; Acute Metabolic Encephalopathy